GILL DAVID N

CIK 000110651911 companiesNORTH MELBOURNE

SEC Profile

Transactions

Companies

Filings

CIK

0001106519

Recent Transactions

50 trades

Award
Evolus, Inc.$EOLS
Common Stock
2026-02-17+45,559→ 86,887 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−16,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−11,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−11,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−16,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−13,950→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−24,000→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Common Stock
2025-09-16$8.60/sh−5,825→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−14,545→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-09-16−33,450→ 0 total
Disposition to Issuer
Y-mAbs Therapeutics, Inc.
Common Stock
2025-09-16−25,080→ 0 total
Award
Y-mAbs Therapeutics, Inc.
Common Stock
2025-06-30+25,080→ 30,905 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2025-06-30+33,450→ 33,450 total
Award
Evolus, Inc.$EOLS
Stock Option (Right to Buy)
2025-03-07+11,146→ 11,146 total
Award
Evolus, Inc.$EOLS
Common Stock
2025-03-07+7,364→ 41,328 total
Award
Y-mAbs Therapeutics, Inc.
Common Stock
2024-06-11+3,495→ 5,825 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2024-06-11+14,545→ 14,545 total
Sale
Evolus, Inc.$EOLS
Common Stock
2024-05-14$12.60/sh−6,718→ 33,964 total
Sale
Evolus, Inc.$EOLS
Common Stock
2024-05-13$12.72/sh−3,643→ 40,682 total
Award
Evolus, Inc.$EOLS
Stock Option (Right to Buy)
2024-02-07+9,377→ 9,377 total
Award
Evolus, Inc.$EOLS
Common Stock
2024-02-07+6,464→ 44,325 total
Award
Y-mAbs Therapeutics, Inc.
Common Stock
2023-06-08+2,330→ 2,330 total
Award
Y-mAbs Therapeutics, Inc.
Employee Stock Option (right to buy)
2023-06-08+13,950→ 13,950 total
Award
Evolus, Inc.$EOLS
Common Stock
2023-01-27+8,293→ 37,861 total
Award
Evolus, Inc.$EOLS
Stock Option (Right to Buy)
2023-01-27+11,789→ 11,789 total
Award
Y-mAbs Therapeutics, Inc.
Non-Employee Stock Option (right to buy)
2022-07-15+16,000→ 16,000 total
Sale
Evolus, Inc.$EOLS
Common Stock
2022-05-16$13.62/sh−5,000→ 29,568 total
Sale
Evolus, Inc.$EOLS
Common Stock
2022-05-13$13.10/sh−5,313→ 34,568 total
Award
Evolus, Inc.$EOLS
Stock Option (Right to Buy)
2022-01-24+22,727→ 22,727 total
Award
Evolus, Inc.$EOLS
Common Stock
2022-01-24+15,568→ 39,881 total
Disposition to Issuer
Strongbridge Biopharma plc
Ordinary Shares
2021-10-05−78,058→ 0 total
Tax Payment
Strongbridge Biopharma plc
Ordinary Shares
2021-10-01$2.06/sh−17,763→ 78,058 total
Award
Y-mAbs Therapeutics, Inc.
Non-Employee Stock Option (right to buy)
2021-06-10+16,000→ 16,000 total
Award
Strongbridge Biopharma plc
Ordinary Shares
2021-05-18+40,000→ 95,821 total
Tax Payment
Strongbridge Biopharma plc
Ordinary Shares
2021-05-14$2.35/sh−19,075→ 55,821 total
Award
Evolus, Inc.$EOLS
Common Stock
2021-02-05+19,313→ 24,313 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2021-01-19$46.52/sh−2,000→ 0 total
Exercise/Conversion
Y-mAbs Therapeutics, Inc.
Non-Employee Stock Option (right to buy)
2021-01-19−2,000→ 24,000 total
Exercise/Conversion
Y-mAbs Therapeutics, Inc.
Common Stock
2021-01-19$11.16/sh+2,000→ 2,000 total
Exercise/Conversion
Y-mAbs Therapeutics, Inc.
Non-Employee Stock Option (right to buy)
2020-11-18−2,000→ 26,000 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2020-11-18$45.77/sh−2,000→ 0 total
Exercise/Conversion
Y-mAbs Therapeutics, Inc.
Common Stock
2020-11-18$11.16/sh+2,000→ 2,000 total
Sale
Y-mAbs Therapeutics, Inc.
Common Stock
2020-11-03$45.00/sh−4,000→ 0 total
Exercise/Conversion
Y-mAbs Therapeutics, Inc.
Non-Employee Stock Option (right to buy)
2020-11-03−4,000→ 28,000 total
Exercise/Conversion
Y-mAbs Therapeutics, Inc.
Common Stock
2020-11-03$11.16/sh+4,000→ 4,000 total
Purchase
Strongbridge Biopharma plc
Ordinary Shares
2020-09-24$2.13/sh+8,000→ 74,896 total
Tax Payment
Strongbridge Biopharma plc
Ordinary Shares
2020-09-03$3.61/sh−23,104→ 66,896 total
Award
Y-mAbs Therapeutics, Inc.
Non-Employee Stock Option (right to buy)
2020-06-23+16,000→ 16,000 total
Award
Strongbridge Biopharma plc
Ordinary Shares
2020-05-14+40,000→ 90,000 total
Award
Evolus, Inc.$EOLS
Stock Option (Right to Buy)
2020-01-23+23,458→ 23,458 total

Companies

Recent Filings

Address

C/O TELIX PHARMACEUTICALS LTD 55 FLEMINGTON RD

NORTH MELBOURNE, 3051

View on SEC.gov